GenAI in Life Sciences: Driving Project Success Amid Complexity
The life sciences industry is entering a new era, with clinical trials reaching a $61B market and pharmaceutical revenues projected at $3T by 2034. As project complexity grows, this session explores how Generative AI (GenAI) is transforming project delivery through streamlining processes, enhancing communication, and driving proactive decision-making.
Presenters: Emil Andersson, Samuel Pownall, Claudia Campbell-Matland, Kamil Mroz, Joann OConnor, Michael Bianchi
PDUs - 0.5 - Business Acumen | 0.5 Ways of Working
It is no longer possible to register for this event
